Back to Results
First PageMeta Content
Long-term nonprogressor / Millennium Development Goals / HIV / AIDS / Zidovudine / Antiviral drug / HIV vaccine / Division of Acquired Immunodeficiency Syndrome / HIV/AIDS / Medicine / Health


PRESS RELEASE Under embargo till July 20, 9 a.m. EST Washington, D.C., July 20, A new initiative, the Collaboration for HIV/AIDS Immunological Therapy (CHAIT), will be announced at the HIV Functional Cure Symposi
Add to Reading List

Document Date: 2013-07-16 05:13:56

Open Document

File Size: 448,58 KB

Share Result on Facebook

City

Lausanne / Washington DC / /

Company

GlaxoSmithKline / University Paris Est Créteil / Sanofi / ANRS/INSERM / /

Country

Switzerland / France / /

/

Event

Business Partnership / /

Facility

Vaccine Research Institute / Mondor Hospital / Lausanne University Hospital / Swiss Vaccine Research Institute / /

IndustryTerm

pharmaceutical / collaborative network / /

MedicalCondition

cancer / HIV / malaria / HCV / AIDS / infectious diseases / HIV/AIDS / latent HIV infection / influenza / tuberculosis / /

MedicalTreatment

antiretroviral therapy / vaccination / /

Organization

French Government / Swiss Vaccine Research Institute in Switzerland / Mondor Hospital / Swiss Secretariat of Education and Research / Danièle Castle Press Office for CHAIT Mobile / Lausanne University Hospital / Vaccine Research Institute in France / International AIDS Society / /

Person

Françoise Barre-Sinoussi / Yves Levy / Giuseppe Pantaleo / /

/

Position

President / info@genevensis.com Editor / /

URL

www.swissvaccineresearchinstitute.ch / /

SocialTag